David M Goldstein - Net Worth and Insider Trading

David M Goldstein Net Worth

The estimated net worth of David M Goldstein is at least $3 Million dollars as of 2024-04-29. David M Goldstein is the Chief Scientific Officer of Principia Biopharma Inc and owns about 31,739 shares of Principia Biopharma Inc (PRNB) stock worth over $3 Million. Details can be seen in David M Goldstein's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David M Goldstein has not made any transactions after 2020-08-10 and currently still holds the listed stock(s).

Transaction Summary of David M Goldstein

To

David M Goldstein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David M Goldstein owns 1 companies in total, including Principia Biopharma Inc (PRNB) .

Click here to see the complete history of David M Goldstein’s form 4 insider trades.

Insider Ownership Summary of David M Goldstein

Ticker Comapny Transaction Date Type of Owner
PRNB Principia Biopharma Inc 2020-09-28 Chief Scientific Officer

David M Goldstein Latest Holdings Summary

David M Goldstein currently owns a total of 1 stock. David M Goldstein owns 31,739 shares of Principia Biopharma Inc (PRNB) as of August 10, 2020, with a value of $3 Million.

Latest Holdings of David M Goldstein

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PRNB Principia Biopharma Inc 2020-08-10 31,739 100.05 3,175,487

Holding Weightings of David M Goldstein


David M Goldstein Form 4 Trading Tracker

According to the SEC Form 4 filings, David M Goldstein has made a total of 4 transactions in Principia Biopharma Inc (PRNB) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Principia Biopharma Inc is the sale of 6,000 shares on August 10, 2020, which brought David M Goldstein around $531,660.

Insider Trading History of David M Goldstein

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David M Goldstein Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David M Goldstein Ownership Network

Ownership Network List of David M Goldstein

No Data

Ownership Network Relation of David M Goldstein


David M Goldstein Owned Company Details

What does Principia Biopharma Inc do?

Who are the key executives at Principia Biopharma Inc?

David M Goldstein is the Chief Scientific Officer of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Business Officer Roy C. Hardiman .

Principia Biopharma Inc (PRNB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Principia Biopharma Inc Insider Transactions

No Available Data

David M Goldstein Mailing Address

Above is the net worth, insider trading, and ownership report for David M Goldstein. You might contact David M Goldstein via mailing address: C/o Principia Biopharma Inc. 400 East Jamie Court, Suite 302 South San Francisco Ca 94080.

Discussions on David M Goldstein

No discussions yet.